PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative dis…
Author: Business Wire
Gemini Therapeutics Announces Presentation of Preclinical Data at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today …
KOVR — New Edmonton-Developed VR Software Helping Diabetes Patients Now Being Tested on Ophthalmology Patients
EDMONTON, Alberta–(BUSINESS WIRE)–Local VR developer begins beta testing its new software platform, Stratos, in limited clinical testing.
National Vision is Named One of America’s Best Employers for Diversity by Forbes
DULUTH, Ga.–(BUSINESS WIRE)—- $EYE–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced today that it has been recognized as one of Forbes’ Best Em…
First Segment of Kopin’s Three Part Webinar Series "AR and VR: The Paradigm Shift to Smartglasses Starts Now" Draws Over 300 Participants
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of transmissive and reflective active matrix liquid crystal and organic light emitting diode (OLED) microdisplays used in military, enterprise, ind…
Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
NovaBay Pharmaceuticals to Hold First Quarter 2021 Conference Call on May 6
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three months ended March 31, 2021 after market close on Thursday, May 6, 2021 and will hold an investment commun…
Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Q-State Biosciences Presents at the 2021 Neuroimmunology Drug Development Summit
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Q-State Biosciences announces new data presented at the 2021 Neuroimmunology Drug Development Summit.
Aldeyra Therapeutics, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseas…
Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
GENEVA–(BUSINESS WIRE)–Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Earlier Detection of Cancer in Minorities Holds Promise to Close Persistent Disparities in Health Outcomes
WASHINGTON–(BUSINESS WIRE)–Today at the National Minority Quality Forum (NMQF) Summit on Health Disparities and Health Braintrust, Gary A. Puckrein, Ph.D., President and CEO of NMQF, announced a new paper entitled “Late-Stage Diagnosis of Unscreened …
Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon shareholders approve all binding resolutions at the 2021 Annual General Meeting
UnitedHealthcare Enhances Integration of Medical and Specialty Benefits, Helping Improve Health Outcomes and Affordability
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare has introduced various enhancements to its integrated approach to medical and specialty benefits, providing members with a more simplified experience and enabling employers to help improve employee h…
Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
Ocular Therapeutix™ To Report First Quarter 2021 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fir…
Kala Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report fi…
Aerie Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Global Dry Eye Disease Market (2021 to 2026) – Insights, COVID-19 Impact, Competition and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Disease (DED) Market – Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By Country (2021 Edition): Market Insights, Covid -19 Impact, Competition and …